SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060224
Filing Date
2023-11-07
Accepted
2023-11-07 16:05:28
Documents
60
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q stok-20230930.htm   iXBRL 10-Q 2471688
2 EX-31.1 stok-ex31_1.htm EX-31.1 17934
3 EX-31.2 stok-ex31_2.htm EX-31.2 17746
4 EX-32.1 stok-ex32_1.htm EX-32.1 9088
5 EX-32.2 stok-ex32_2.htm EX-32.2 10161
  Complete submission text file 0000950170-23-060224.txt   7134921

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stok-20230930_def.xml EX-101.DEF 99795
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stok-20230930_lab.xml EX-101.LAB 314998
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stok-20230930_cal.xml EX-101.CAL 40330
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stok-20230930.xsd EX-101.SCH 44354
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stok-20230930_pre.xml EX-101.PRE 219898
54 EXTRACTED XBRL INSTANCE DOCUMENT stok-20230930_htm.xml XML 1141259
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 231383638
SIC: 2834 Pharmaceutical Preparations